Oruka Therapeutics, Inc.
ORKA
$10.09
-$0.36-3.45%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 375.65M | 410.88M | 15.12M | 27.74M | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 1.22M | 2.07M | 1.43M | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | 275.00K | -- | |
| Total Current Assets | 376.87M | 412.95M | 16.82M | 27.74M | |
|
|
|||||
| Total Current Assets | 376.87M | 412.95M | 16.82M | 27.74M | |
| Net Property, Plant & Equipment | 1.04M | 1.10M | 999.00K | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 43.00K | 43.00K | 2.36M | 488.00K | |
| Total Assets | 396.02M | 414.09M | 20.18M | 28.23M | |
|
|
|||||
| Total Accounts Payable | 3.46M | 2.15M | 2.58M | 4.00K | |
| Total Accrued Expenses | 9.37M | 8.07M | 16.29M | 7.04M | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 213.00K | 146.00K | 61.00K | -- | |
| Total Finance Division Other Current Liabilities | -- | 7.68M | 430.00K | 124.00K | |
| Total Other Current Liabilities | -- | 7.68M | 430.00K | 124.00K | |
| Total Current Liabilities | 13.04M | 18.04M | 19.36M | 7.17M | |
|
|
|||||
| Total Current Liabilities | 13.04M | 18.04M | 19.36M | 7.17M | |
| Long-Term Debt | -- | -- | 24.98M | 24.98M | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 755.00K | 842.00K | 925.00K | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | 961.00K | 214.00K | |
| Total Liabilities | 13.80M | 18.88M | 46.23M | 32.36M | |
|
|
|||||
| Common Stock & APIC | 463.06M | 397.38M | 339.00K | 18.00K | |
| Retained Earnings | -83.72M | -57.94M | -29.32M | -7.08M | |
| Treasury Stock & Other | -41.00K | -- | -- | -- | |
| Total Common Equity | 379.29M | 339.44M | -28.98M | -7.06M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | 2.93M | 55.77M | 2.93M | 2.93M | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | 2.93M | 55.77M | 2.93M | 2.93M | |
|
|
|||||
| Total Common Equity | 379.29M | 339.44M | -28.98M | -7.06M | |
| Total Preferred Equity | 2.93M | 55.77M | 2.93M | 2.93M | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 382.22M | 395.21M | -26.05M | -4.13M | |
|
|
|||||